摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-3-(3-fluoro-4-hydroxyphenyl)-2-fluoroacrylic acid ethyl ester | 854016-18-5

中文名称
——
中文别名
——
英文名称
(Z)-3-(3-fluoro-4-hydroxyphenyl)-2-fluoroacrylic acid ethyl ester
英文别名
ethyl (Z)-2-fluoro-3-(3-fluoro-4-hydroxyphenyl)prop-2-enoate
(Z)-3-(3-fluoro-4-hydroxyphenyl)-2-fluoroacrylic acid ethyl ester化学式
CAS
854016-18-5
化学式
C11H10F2O3
mdl
——
分子量
228.195
InChiKey
XOHUYOAHVFJNTQ-TWGQIWQCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Isoxazole derivatives as peroxisome proliferator-activated receptors agonists
    申请人:Fukui Yoshikazu
    公开号:US20070054902A1
    公开(公告)日:2007-03-08
    A compound of formula (I): (wherein R 1 -R 10 are each independently hydrogen, halogen, optionally substituted lower alkyl or the like, X 1 is —O—, —S—, —NR 11 — (wherein R 11 is hydrogen, lower alkyl or the like), —CR 12 R 13 CO—, —(CR 12 R 13 )mO—, —O(CR 12 R 13 )m- (wherein R 12 and R 13 are each independently hydrogen or lower alkyl and m is a integer between 1 and 3) or the like, X 2 is a bond, —O—, —S—, —NR 14 — (wherein R 14 is hydrogen, lower alkyl or the like, R 14 and R 6 can be taken together with the neighboring atom to form a ring) or —CR 15 R 16 — (wherein R 15 and R 16 are each independently hydrogen or lower alkyl, R 15 and R 6 or R 10 can be taken together with the neighboring carbon atom to form a ring, R 16 and R 9 can be joined together to form a bond), X 3 is COOR 17 , C(═NR 17 )NR 18 OR 19 or the like), a pharmaceutically acceptable salt or a solvate thereof.
    化合物的化学式为(I):(其中R1-R10各自独立地为氢,卤素,可选择性取代的低碳基或类似物,X1为—O—,—S—,—NR11—(其中R11为氢,低碳基或类似物),—CR12R13CO—,—(CR12R13)mO—,—O(CR12R13)m-(其中R12和R13各自独立地为氢或低碳基,m为1到3之间的整数)或类似物,X2为键,—O—,—S—,—NR14—(其中R14为氢,低碳基或类似物,R14和R6可以与相邻的原子结合形成环)或—CR15R16—(其中R15和R16各自独立地为氢或低碳基,R15和R6或R10可以与相邻的碳原子结合形成环,R16和R9可以结合在一起形成键),X3为COOR17,C(═NR17)NR18OR19或类似物),其药学上可接受的盐或溶剂化物。
  • ISOXAZOLE DERIVATIVE HAVING AGONISTIC ACTIVITY AGAINST PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR
    申请人:SHIONOGI & CO., LTD.
    公开号:EP1690538A1
    公开(公告)日:2006-08-16
    A compound of formula (I) : (wherein R1-R10 are each independently hydrogen, halogen, optionally substituted lower alkyl or the like, X1 is -O-, -S-, -NR11- (wherein R11 is hydrogen, lower alkyl or the like), -CR12R13CO-, -(CR12R13)mO-, -O(CR12R13)m- (wherein R12 and R13 are each independently hydrogen or lower alkyl and m is a integer between 1 and 3) or the like, X2 is a bond, -O-, -S-, -NR14- (wherein R14 is hydrogen, lower alkyl or the like, R14 and R6 can be taken together with the neighboring atom to form a ring) or -CR15R16-(wherein R15 and R16 are each independently hydrogen or lower alkyl, R15 and R6 or R10 can be taken together with the neighboring carbon atom to form a ring, R16 and R9 can be joined together to form a bond), X3 is COOR17, C( = NR17)NR18OR19 or the like), a pharmaceutically acceptable salt or a solvate thereof.
    式 (I) 的化合物: 其中 R1-R10各自独立地为氢、卤素、任选取代的低级烷基或类似物,X1为-O-、-S-、-NR11-(其中R11为氢、低级烷基或类似物)、-CR12R13CO-、-(CR12R13)mO-、-O(CR12R13)m-(其中R12和R13各自独立地为氢或低级烷基,m为1至3之间的整数)或类似物、 X2 是键、-O-、-S-、-NR14-(其中 R14 是氢、低级烷基或类似物,R14 和 R6 可与邻近原子一起形成环)或-CR15R16-(其中 R15 和 R16 各自独立地是氢或低级烷基、R15和R6或R10可与邻近的碳原子结合形成环,R16和R9可结合形成键),X3为COOR17、C( = NR17)NR18OR19或类似物),其药学上可接受的盐或溶液。
  • EP1690538
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多